Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 2
2011 3
2012 2
2013 5
2014 6
2015 10
2016 4
2017 8
2018 7
2019 9
2020 13
2021 8
2022 10
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant immune-checkpoint inhibitors in lung cancer - a primer for radiologists.
Kifjak D, Hochmair MJ, Krenbek D, Milos RI, Heidinger BH, Prayer F, Röhrich S, Watzenboeck ML, Oberndorfer F, Klikovits T, Aigner C, Sinn K, Hoda MA, Hoetzenecker K, Haug AR, Prosch H, Beer L. Kifjak D, et al. Among authors: haug ar. Eur J Radiol. 2023 Apr;161:110732. doi: 10.1016/j.ejrad.2023.110732. Epub 2023 Feb 8. Eur J Radiol. 2023. PMID: 36804313 Free article. Review.
The role of SPECT/CT in radioembolization of liver tumours.
Ahmadzadehfar H, Duan H, Haug AR, Walrand S, Hoffmann M. Ahmadzadehfar H, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 1:S115-24. doi: 10.1007/s00259-013-2675-5. Epub 2014 Jan 18. Eur J Nucl Med Mol Imaging. 2014. PMID: 24442600 Review.
Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Spielvogel CP, Stoiber S, Papp L, Krajnc D, Grahovac M, Gurnhofer E, Trachtova K, Bystry V, Leisser A, Jank B, Schnoell J, Kadletz L, Heiduschka G, Beyer T, Hacker M, Kenner L, Haug AR. Spielvogel CP, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):546-558. doi: 10.1007/s00259-022-05973-9. Epub 2022 Sep 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 36161512 Free PMC article.
Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma.
Berzaczy D, Fueger B, Hoeller C, Haug AR, Staudenherz A, Berzaczy G, Weber M, Mayerhoefer ME. Berzaczy D, et al. Among authors: haug ar. Mol Imaging Biol. 2020 Jun;22(3):739-744. doi: 10.1007/s11307-019-01413-7. Mol Imaging Biol. 2020. PMID: 31363965
(R)-[18F]NEBIFQUINIDE: A promising new PET tracer for TSPO imaging.
Berroterán-Infante N, Kalina T, Fetty L, Janisch V, Velasco R, Vraka C, Hacker M, Haug AR, Pallitsch K, Wadsak W, Mitterhauser M. Berroterán-Infante N, et al. Among authors: haug ar. Eur J Med Chem. 2019 Aug 15;176:410-418. doi: 10.1016/j.ejmech.2019.05.008. Epub 2019 May 10. Eur J Med Chem. 2019. PMID: 31125895
Dynamic [18F]FET-PET/MRI using standard MRI-based attenuation correction methods.
Rausch I, Zitterl A, Berroterán-Infante N, Rischka L, Prayer D, Fenchel M, Sareshgi RA, Haug AR, Hacker M, Beyer T, Traub-Weidinger T. Rausch I, et al. Among authors: haug ar. Eur Radiol. 2019 Aug;29(8):4276-4285. doi: 10.1007/s00330-018-5942-9. Epub 2019 Jan 11. Eur Radiol. 2019. PMID: 30635757 Free PMC article.
83 results